What it is
LL-37 is the active 37-amino acid C terminal fragment of the human cathelicidin antimicrobial peptide precursor hCAP18.
How it works
In research models, LL-37 is studied as a host defense peptide active across multiple microbial-research models, with additional research interest in immune modulation pathways.
What researchers explore it for
Researchers have explored LL-37 in antimicrobial pathway research, in immune modulation research, and in wound research models.
Safety and interactions
LL-37 is for laboratory research use only and is not for human consumption. Not medical advice.
Research notes
Peptide family: cathelicidin derived antimicrobial peptides. Currently on PCAC review docket — Apothify is not shipping LL-37 at V1 launch.